U.S. lawmakers look to close trading loopholes Sep. 17, 2020 By Mari Serebrov No Comments Spurred by reports of biopharma executives exercising stock options in conjunction with announcements about COVID-19 vaccine developments and government contracts, U.S. lawmakers want to close the loopholes that make such actions legal.Read More